Huntington National Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Huntington National Bank’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,127	Closed	-$336K	–	3844
2023 Q1	$336K	Hold	3,127	–	–	﹤0.01%	534
2022 Q4	$344K	Buy	+3,127	New	+$203K	﹤0.01%	522

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Huntington National Bank's RXDX Position: Q2 2023 in Review

Huntington National Bank sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 3,127 shares — an estimated $336K sold.

Huntington National Bank first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $344K in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Huntington National Bank reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Huntington National Bank sold 3,127 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $336K.
Huntington National Bank first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Huntington National Bank's Prometheus Biosciences, Inc. Common Stock position peaked at $344K in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Huntington National Bank's 13F filing for Q2 2023, filed 11 Aug 2023.